Prothena Corporation plc
PRTA · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Market Cap | $1 | $2 | $3 | $2 |
| - Cash | $0 | $1 | $1 | $1 |
| + Debt | $0 | $0 | $0 | $0 |
| Enterprise Value | $0 | $1 | $2 | $2 |
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | 47.9% | 69.5% | -73.1% | – |
| Gross Profit | $0 | $0 | $0 | $0 |
| % Margin | 100% | 100% | 100% | 100% |
| EBITDA | -$0 | -$0 | -$0 | $0 |
| % Margin | -113.7% | -208.1% | -242.7% | 36.4% |
| Net Income | -$0 | -$0 | -$0 | $0 |
| % Margin | -90.5% | -160.9% | -217% | 33.4% |
| EPS Diluted | -2.27 | -2.76 | -2.47 | 1.38 |
| % Growth | 17.8% | -11.7% | -279% | – |
| Operating Cash Flow | -$0 | -$0 | -$0 | $0 |
| Capital Expenditures | -$0 | -$0 | -$0 | -$0 |
| Free Cash Flow | -$0 | -$0 | -$0 | $0 |